Equities

BioVie Inc

BIVI:NAQ

BioVie Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.35
  • Today's Change0.36 / 12.04%
  • Shares traded4.84m
  • 1 Year change-89.79%
  • Beta0.9548
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments243419
Total Receivables, Net------
Total Inventory------
Prepaid expenses0.200.100.14
Other current assets, total------
Total current assets243419
Property, plant & equipment, net0.410.080.12
Goodwill, net0.350.350.35
Intangibles, net0.410.640.87
Long term investments------
Note receivable - long term------
Other long term assets--00.00
Total assets253520
LIABILITIES
Accounts payable------
Accrued expenses0.060.040.04
Notes payable/short-term debt000
Current portion long-term debt/capital leases5.709.11--
Other current liabilities, total0.001.871.69
Total current liabilities9.35144.17
Total long term debt05.2312
Total debt5.701412
Deferred income tax------
Minority interest------
Other liabilities, total0.350.040.14
Total liabilities9.702016
SHAREHOLDERS EQUITY
Common stock0.010.000.00
Additional paid-in capital350316255
Retained earnings (accumulated deficit)(334)(301)(251)
Treasury stock - common0.000--
Unrealized gain (loss)------
Other equity, total--0.18--
Total equity16153.67
Total liabilities & shareholders' equity253520
Total common shares outstanding6.193.642.50
Treasury shares - common primary issue0.030.000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.